Delivery Order SPE2DB22D9367-SPE2DB24FSZ49

Award Date 8/30/24
Potential Completion Date 9/3/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $35,388.40 for the supply of JAKAFI 15 MG TABLET 60S. The contract is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which allows the DLA to issue firm fixed-price delivery orders for a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,773.87 firm fixed-price delivery order is for the supply of JAKAFI 15 MG TABLET 60S, a pharmaceutical product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) under the DLA's SPE2DB program, which allows the agency to issue delivery orders for a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,794.12 firm fixed-price delivery order is for the supply of JAKAFI 20 MG TABLET 60S, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999 that runs through December 31, 2025. This single-award IDC...
The U.S. government agency Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,840.66 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of the pharmaceutical product JAKAFI 10 MG TABLET 60S. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program. The...
This is a federal contract award by the Defense Logistics Agency (DLA) under its Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $35,521.98, is for the delivery of 4,564,491,839 tablets of the prescription drug JAKAFI 10 MG to support the recurring medical supply needs of military health facilities. The contract is a delivery order under a broader indefinite delivery contract (IDC) valued at up to...
This federal contract award, valued at $11,840.66, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4565713016 - JAKAFI 10 MG TABLET 60S, with a performance period through September 9, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD), to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,152.01 firm fixed-price delivery order is for the supply of the pharmaceutical product "JAKAFI 10 MG TABLET 60S" and has a completion date of July 29, 2024. DMS Pharmaceutical Group holds a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,794.12, is for the delivery of JAKAFI 20 MG TABLET 60S, a specialized pharmaceutical product. The delivery order was awarded under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999 and valid through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $11,840.66, is for the delivery of JAKAFI 10 MG TABLET 60S, a prescription medication. The contract is a firm fixed-price delivery order with no set-aside designation. It has an ultimate completion date of September 26, 2024. DMS Pharmaceutical Group holds a larger indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,794.12, is for the delivery of 4,564,536,826 units of the prescription drug JAKAFI 20 MG TABLET 60S. The award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999 and running through December 31,...
  • SPE2DB22D9367
    Indefinite Delivery Contract
  • SPE2DB22D9367-SPE2DB24FSZ49
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,773.87 firm fixed-price delivery order is for the supply of JAKAFI 15 MG TABLET 60S, and is part of a larger $499,999,999 indefinite delivery contract (IDC) that allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. This IDC, which runs through December 31, 2025, does not have a set-aside designation and leverages DMS Pharmaceutical Group's status as a woman-owned small business to secure direct awards for pharmaceutical Prime Vendor programs supporting Department of Defense (DoD) healthcare facilities globally. Through this vehicle and other prime vendor contracts, DMS Pharmaceutical Group provides a wide array of medications, from common drugs to specialized pharmaceuticals and medical supplies, to the DoD and Department of Veterans Affairs.

Generated 11/29/24, 9:05 AM